Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells

Journal of Immunology

Volumn 183, Issue 2, 2009, Pages 897-906

  Andresen, Lars ^a   Hansen, Karen Aagaard ^a   Jensen, Helle ^a   Pedersen, Stine Falsig ^a   Stougaard, Peter ^a   Hansen, Helle Rüsz ^a   Jurlander, Jesper ^b   Skov, Søren ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b State Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BUTYRIC ACID; CALCIUM; LACTIC ACID; MHC CLASS I POLYPEPTIDE RELATED SEQUENCE A; MHC CLASS I POLYPEPTIDE RELATED SEQUENCE B; NATURAL KILLER CELL RECEPTOR NKG2D; POLYPEPTIDE; PROPIONIC ACID; ROMIDEPSIN; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; KLRK1 PROTEIN, HUMAN; LIGAND; MHC CLASS I RELATED CHAIN A; MHC CLASS I-RELATED CHAIN A; MICB ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; PROPIONIC ACID DERIVATIVE;

ACID SECRETION; ARTICLE; BACTERIAL METABOLISM; CALCIUM CELL LEVEL; CANCER CELL; CANCER PREVENTION; CELL METABOLISM; COMPETITIVE INHIBITION; CONTROLLED STUDY; GENE DELETION; GLYCOLYSIS; HUMAN; HUMAN CELL; IMMUNOREGULATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROPIONIBACTERIUM; PROPIONIBACTERIUM FREUDENREICHII; PROPIONIBACTERIUM FREUDENREICHII SHERMANII; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION SITE; BACTERIUM; BLOOD DISEASE; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

BACTERIA; CALCIUM; CELL LINE, TUMOR; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; JURKAT CELLS; LIGANDS; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PROMOTER REGIONS, GENETIC; PROPIONIC ACIDS; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 70249146929     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803014     Document Type: Article

References (42)

1. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729. (Pubitemid 129505074)
2. Groh, V., A. Bruhl, H. El-Gabalawy, J. L. Nelson, and T. Spies. 2003. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 100: 9452-9457.
3. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
4. Bacon, L., R. A. Eagle, M. Meyer, N. Easom, N. T. Young, and J. Trowsdale. 2004. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 173: 1078-1084. (Pubitemid 38924282)
5. Groh, V., S. Bahram, S. Bauer, A. Herman, M. Beauchamp, and T. Spies. 1996. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93: 12445-12450.
6. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, T. Suzuki, T. Miyagi, and N. Hayashi. 2003. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J. Immunol. 171: 5423-5429. (Pubitemid 37432829)
7. Jinushi, M., T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi, T. Suzuki, Y. Sasaki, and N. Hayashi. 2003. Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J. Immunol. 170: 1249-1256. (Pubitemid 36139490)
8. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, R. Kimura, T. Miyagi, K. Mochizuki, Y. Sasaki, and N. Hayashi. 2003. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer. 104: 354-361.
9. Schreiner, B., J. Voss, J. Wischhusen, Y. Dombrowski, A. Steinle, H. Lochmuller, M. Dalakas, A. Melms, and H. Wiendl. 2006. Expression of Toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release and up-regulation of NKG2D-ligands. FASEB J. 20: 118-120.
10. Gasser, S., S. Orsulic, E. J. Brown, and D. H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
11. Vales-Gomez, M., S. E. Chisholm, R. L. Cassady-Cain, P. Roda-Navarro, and H. T. Reyburn. 2008. Selective induction of expression of a ligand for the NKG2D receptor by proteasome inhibitors. Cancer Res. 68: 1546-1554.
12. Skov, S., M. T. Pedersen, L. Andresen, P. T. Straten, A. Woetmann, and N. Odum. 2005. Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B. Cancer Res. 65: 11136-11145.
13. Armeanu, S., M. Bitzer, U. M. Lauer, S. Venturelli, A. Pathil, M. Krusch, S. Kaiser, J. Jobst, I. Smirnow, A. Wagner, et al. 2005. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate. Cancer Res. 65: 6321-6329.
14. Venkataraman, G. M., D. Suciu, V. Groh, J. M. Boss, and T. Spies. 2007. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J. Immunol. 178: 961-969.
15. Jan, G., A. S. Belzacq, D. Haouzi, A. Rouault, D. Metivier, G. Kroemer, and C. Brenner. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9: 179-188.
16. Scheppach, W., H. P. Bartram, and F. Richter. 1995. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur. J. Cancer 31A: 1077-1080.
17. Isenberg, J., B. Stoffel, U. Wolters, J. Beuth, H. Stutzer, H. L. Ko, and H. Pichlmaier. 1995. Immunostimulation by propionibacteria: effects on immune status and antineoplastic treatment. Anticancer Res. 15: 2363-2368.
18. Isenberg, J., H. Ko, G. Pulverer, R. Grundmann, H. Stutzer, and H. Pichlmaier. 1994. Preoperative immunostimulation by Propionibacterium granulosum KP-45 in colorectal cancer. Anticancer Res. 14: 1399-1404. (Pubitemid 24264196)
19. Kim, J., M. T. Ochoa, S. R. Krutzik, O. Takeuchi, S. Uematsu, A. J. Legaspi, H. D. Brightbill, D. Holland, W. J. Cunliffe, S. Akira, et al. 2002. Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. J. Immunol. 169: 1535-1541.
20. Kim, J. 2005. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211: 193-198.
21. Desviat, L. R., B. Perez, C. Perez-Cerda, P. Rodriguez-Pombo, S. Clavero, and M. Ugarte. 2004. Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol. Genet. Metab. 83: 28-37.
22. Deodato, F., S. Boenzi, F. M. Santorelli, and C. Dionisi-Vici. 2006. Methylmalonic and propionic aciduria. Am. J. Med. Genet. C. Semin. Med. Genet. 142C: 104-112.
23. Al Essa, M., Z. Rahbeeni, S. Jumaah, S. Joshi, J. E. Al, M. S. Rashed, A. M. Al, and P. T. Ozand. 1998. Infectious complications of propionic acidemia in Saudia Arabia. Clin. Genet. 54: 90-94.
24. Kane, K. L., F. A. Ashton, J. L. Schmitz, and J. D. Folds. 1996. Determination of natural killer cell function by flow cytometry. Clin. Diagn. Lab. Immunol. 3: 295-300. (Pubitemid 26189629)
25. Andresen, L., H. Jensen, M. T. Pedersen, K. A. Hansen, and S. Skov. 2007. Molecular regulation of MHC class I chain-related protein A expression after HDAC-inhibitor treatment of Jurkat T cells. J. Immunol. 179: 8235-8242.
26. + exchanger in Ehrlich ascites tumor cells: mechanisms involved in the activation and a role for the exchanger in cell volume regulation. J. Membr. Biol. 149: 141-159.
27. Hansen, H. R., C. Hansen, K. P. Jensen, S. H. Hansen, S. Sturup, and B. Gammelgaard. 2008. Characterization of sodium stibogluconate by online liquid separation cell technology monitored by ICPMS and ESMS and computational chemistry. Anal. Chem. 80: 5993-6000.
28. Yonezawa, T., Y. Kobayashi, and Y. Obara. 2007. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell. Signal. 19: 185-193.
29. (i) changes through calcium flux, ERK1/2, p38, and PKC in bovine neutrophils. Vet. Immunol. Immunopathol. 115: 286-298.
30. 2+, and acidosis-mediated neuronal injury by intracellular pH. J. Biol. Chem. 281: 29369-29378.
31. Cousens, L. S., D. Gallwitz, and B. M. Alberts. 1979. Different accessibilities in chromatin to histone acetylase. J. Biol. Chem. 254: 1716-1723.
32. Maciver, N. J., S. R. Jacobs, H. L. Wieman, J. A. Wofford, J. L. Coloff, and J. C. Rathmell. 2008. Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukocyte Biol. 84: 949-957.
33. Lopez-Lazaro, M. 2008. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med. Chem. 8: 305-312.
34. Kurtoglu, M., J. C. Maher, and T. J. Lampidis. 2007. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxid. Redox Signal. 9: 1383-1390.
35. Herken, H., and K. Lange. 1969. Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 263: 496-499.
36. Gupte, S. A., R. J. Levine, R. S. Gupte, M. E. Young, V. Lionetti, V. Labinskyy, B. C. Floyd, C. Ojaimi, M. Bellomo, M. S. Wolin, and F. A. Recchia. 2006. Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. J. Mol. Cell. Cardiol. 41: 340-349.
37. Perera, L., L. Shao, A. Patel, K. Evans, B. Meresse, R. Blumberg, D. Geraghty, V. Groh, T. Spies, B. Jabri, and L. Mayer. 2007. Expression of nonclassical class I molecules by intestinal epithelial cells. Inflamm. Bowel Dis. 13: 298-307.
38. Filipowicz, H. R., S. L. Ernst, C. L. Ashurst, M. Pasquali, and N. Longo. 2006. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol. Genet. Metab. 88: 123-130.
39. Nguyen, N. H., C. Morland, S. V. Gonzalez, F. Rise, J. Storm-Mathisen, V. Gundersen, and B. Hassel. 2007. Propionate increases neuronal histone acetylation, but is metabolized oxidatively by glia: relevance for propionic acidemia. J. Neurochem. 101: 806-814.
40. Hue, S., J. J. Mention, R. C. Monteiro, S. Zhang, C. Cellier, J. Schmitz, V. Verkarre, N. Fodil, S. Bahram, N. Cerf-Bensussan, and S. Caillat-Zucman. 2004. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21: 367-377.
41. Meresse, B., Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, T. N. Krausz, D. H. Raulet, L. L. Lanier, V. Groh, T. Spies, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
42. Tursi, A., G. Brandimarte, and G. Giorgetti. 2003. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am. J. Gastroenterol. 98: 839-843. (Pubitemid 36576311)